Mannatech Presents Science At Glycobiology And Medicine Symposium
Two posters about Mannatech’s Ambrotose® technology were presented at the 9th Annual Jenner Glycobiology and Medicine Symposium, held in Brussels, Belgium, September 13‒15, 2009. The first poster, presented by Dr. Robert A. Sinnott, Mannatech’s Chief Science Officer, presented preclinical data indicating that orally administered Advanced Ambrotose® powder has a beneficial effect on gene expression in the colon of healthy mice.* The animal study was conducted by Eurofins/Product Safety Laboratories in New Jersey, and the gene expression analysis was conducted by scientists at University of Texas Southwestern Medical Center at Dallas. Mannatech’s R&D group funded and managed the project and compiled the data.
Researchers at St. George’s University of London presented the second poster, an open-label human study which showed that Advanced Ambrotose® powder supplementation affects the N-glycosylation profile in blood.*
Over 100 participants— from major research groups in the area of glycobiology and medicine, from Europe, Asia and the United States—were in attendance. The meeting was organized by the Royal Society of Medicine (U.K.) in association with the Rega Institute for Medical Research at the Catholic University of Leuven, Belgium.Oct 8, 2009 at 3:01 pm | Press Releases